Q3 FY2026 EarningsQ3 FY26 results beat revenue expectations but missed significantly on GAAP earnings due to non-cash charges. Revenue reached $161.2M (+12% YoY) vs. $149.2M consensus, driven by strong performance in Multiomics and Sample Repository Services. However, the company reported a massive operating loss of $177.2M for the nine-month period, primarily due to a $149.1M goodwill impairment charge across both reporting segments. While adjusted margins improved in Multiomics (+550bps), Sample Management Solutions margins contracted due to project rework costs and inventory reserves.
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Azenta(AZTA) the Revenue is 161.18 M (+11.97%), Beat estimate;the EBIT is 4.707 M (-58.15%), Beat estimate;the EPS is 0.05 (+104.4%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.16B11.97%
0.15B3.68%
+0.01B8.29%
EBITExceed expectations
0.00B58.15%
0.00B75.33%
+0.00B17.18%
EPSExceed expectations
0.05104.35%
-0.05695.13%
+0.10609.22%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf